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Executive Summary
Unsafe abortion has been acknowledged as one of the major causes
of maternal mortality and morbidity in Ghana. According to the
2007 Ghana Maternal Health Survey report, 11% of the reported 451
maternal deaths were abortion related (Macro International, 2009).
With limited numbers of trained service providers and well equipped
facilities to provide surgical abortions, medical non-surgical methods
of terminating pregnancies promises an additional way of increasing
access to safe abortion services as permitted by law and contributing to
reducing maternal mortality and morbidity (Medical Abortion, 2009).
To support the government’s effort in achieving MDG 5, in September
2006, a consortium of five (5) agencies consisting of EngenderHealth,
Ipas, Marie Stopes International - Ghana (MSIG), Population Council
and Willows Foundation, in collaboration with the MOH/GHS and
with funding from an anonymous donor, initiated a program named
Reducing Maternal Mortality and Morbidity (R3M). The program
provides the commitment, financial and technical resources that
enable the government to expand significantly women’s access to
modern family planning and comprehensive abortion care (CAC)
services. MSIG’s focus is in the provision of family planning and
comprehensive abortion care services in the private sector. MSIG’s
mandate also includes the piloting and registration of new technologies
and procedures for abortion care management; a provisional license
was awarded to MSIG by the Ghana Food and Drugs Board (FDB) for
the introduction and provision of the first medical abortion regimen
(Mifepristone and Misoprostol) in Ghana. Population Council
conducted this study to document this introduction process, findings
from the study will provide the much needed evidence based report to
inform policy decision making and the scale-up phase.
The study involved a total of ten health facilities: (4) MSIG centers:
Ashiaman and U-Compound in Tema, Kokomlemle in Accra and
Kumasi and (6) public health facilities: Korle Bu Teaching Hospital,
4

Ridge and La General Hospitals in Greater Accra Region, Koforidua
Regional and Oda Government Hospitals in Eastern Region and
Manhyia Hospital in Ashanti Region. The research team interviewed a
total of 477 clients and 13 health providers. However, due to missing/
incomplete data 461 client and all 13 provider interview data was used
for the preparation of this report.
The study aimed at documenting the introduction of the dual regimen;
Mifepristone and Misoprostol for early pregnancy termination. The
study also examined health providers’ skills, quality of services
delivered, and clients’ satisfaction with the method and provider-patient
interpersonal rapport among others. The results show that the mean
age of clients who sought medical abortion services was about 26 years.
Thirteen (13) percent of all interviewed clients were teenagers between
the ages of 15 and 19 years. The majority of clients (55%) had never
been married while the average number of pregnancy experienced
was about three (3). Eighty three (83) percent of the interviewed
clients had at least completed primary education with about 24% still
being students. Out of the providers interviewed, 10 were midwives,
two (2) were general nurses and one was a medical assistant. Ninety
two percent of all interviewed providers showed good and adequate
knowledge in medical abortion service provision procedures, almost
all, 12 out of 13 service providers knew the accurate and recommended
dosage of Mediprist.
Results also revealed that about 50% of the clients who visited the
facilities had medical abortion in mind whiles the rest had MVA/EVA
in mind. Approximately 93% of all the clients reported that in making
a choice, they were provided with sufficient information on the two
methods available. A total of 73% of all clients’ reasons for choosing
medical abortion over surgical abortion was to avoid anesthesia,
surgery, risk of complications and pain.
After an initial dose of Mediprist, the reported expulsion time of the
product of conception for over 80% of clients was within 24 hours
5

after administration of Misoprostol. For 16% of interviewed clients,
complete expulsion occurred after 24 hours, to complete the expulsion
process for the remaining four (4) percent of clients who had reported
that the product of conception was not expelled, an additional dose
of Misoprostol was given/surgical completion was done at no cost to
them.
The most common side effects mentioned were cramps and bleeding
after the Mediprist and Misoprostol respectively, three in five clients
used a pain medication during the process.
Acceptability of medical abortion procedure was very high; about 81%
of the clients indicated that they will use the method again if they had
to, while about 90% indicated that they will recommend the method
to their family and friends; approximately 85% of the providers were
satisfied with the procedure.

RECOMMENDATIONS
• Scale-up is encouraged given the high success rate with the
medical abortion combined regimen at the study sites.
• Service providers need to be given a thorough orientation
on medical abortion counseling and service provision.
• Family planning counseling should be a major part of the
follow up visit.
• Use of effective contraceptive method should be strongly
encouraged to all clients.
• Clients need to be given adequate information about the
processes/stages, highly encouraged to return for the followup visits.
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Background
The term medical abortion refers to pregnancy termination with
abortion-inducing medications in lieu of primary surgical intervention
(Creinin, 2000). Although the idea of using medications to induce
abortion has been around for centuries, evidence-based regimens for
use in the first trimester of pregnancy only became a reality in the last
25 years. An estimated 22 unsafe abortions occur for every 1000 women
globally. An alarming fifth of all maternal deaths in Africa are due to
complications arising from unsafe abortions. With limited numbers
of trained service providers and fully equipped facilities to provide
surgical abortions, medical non-surgical methods of terminating
pregnancies promises an additional way of increasing access to safe
abortion services and contributing to reducing maternal mortality and
morbidity.
Like most countries in sub-Saharan Africa, Ghana suffers from
high maternal mortality and morbidity due partly to high rates of
unwanted fertility and unsafe abortion and relatively low use of
modern contraception. Although the Government of Ghana has made
impressive gains in recent years, access to reproductive health services
remains poor, particularly so for the majority of the population who
live in rural, impoverished, and isolated communities. Only 17 percent
of married women of reproductive age use modern contraceptive
methods (Macro International 2009), and data from the 2008 Ghana
Demographic and Health Survey indicates that 14 percent of all births
in Ghana are unwanted, 37 percent are unplanned, and 23 percent
are mistimed (Macro International 2009). Mistimed, unplanned,
and unwanted fertility arise from limited access to and use of family
planning services.
In Ghana abortion is a criminal offence regulated by Act 29, section
58 of the Criminal code of 1960, amended by PNDCL 102 of 1985
(Criminal Code of Ghana, 1960). It states that:
7

1. Subject to the provisions of subsection (2) of this section
a. Any woman who with intent to cause abortion or miscarriage
administers to herself or consent to be administered to her any
poison, drug or other noxious thing or uses any instrument or
other means whatsoever; or
b. Any person who
i. Administers to a woman any poison, drug or other noxious
thing or uses any instrument or other means whatsoever with
intent to cause abortion or miscarriage, whether or not the
woman is pregnant or has given her consent;
ii. Induces a woman to cause or consent to causing abortion or
miscarriage;
iii. Aids and abets a woman to cause abortion or miscarriage;
iv. Attempts to cause abortion or miscarriage; or
v. Supplies or procures any poison, drug, instrument or other
thing knowing that it is intended to be used or employed to
cause abortion or miscarriage; shall be guilty of an offence and
liable on conviction to imprisonment for a term not exceeding
five years.
2. It is not an offence under section (1) if an abortion or miscarriage
is caused in any of the following circumstances by a registered medical
practitioner specializing in gynecology or any other registered
medical practitioner in a government hospital or a private hospital
or clinic registered under the Private Hospital and Maternity Home
Act, 1958 (No. 9) or in a place approved for the purpose by legislative
instrument made by the Secretary:
a. Where pregnancy is the result of rape or defilement of a female
idiot or incest and the abortion or miscarriage is requested by
the victim or her next of kin or the person in loco parentis, if
she lacks the capacity to make such request;
b. Where the continuance of the pregnancy would involve risk
to the life of the pregnant woman or injury to her physical or
mental health and such a woman consents to it or if she lacks the
capacity to give such consent it is given on her behalf by her next
of kin or the person in loco parentis;
8

c. Where there is substantial risk that if the child were born
it may suffer from or later develop a serious physical
abnormality or disease.
3. For the purposes of this section Abortion or miscarriage means
premature expulsion or removal of conception from the uterus or
womb before the period of gestation is completed.
The above thus allow Ghanaian women the legal option to terminate
an unwanted pregnancy. Despite this “liberal” law, implementation
of programs to match the policy intentions has been slow; moreover,
knowledge of safe abortion services is also not widespread among
communities. Information gaps remain in key areas such as systematic
documentation of the implementation of the law; the various service
models for safe abortion services; methods for monitoring quality
of care of services; technical resources and updated information of
technologies and procedures.
In 2006, a consortium of five agencies; EngenderHealth, Ipas,
Marie Stopes International, Population Council, and the Willows
Foundation came together to provide technical and financial support
to the Government of Ghana in the provision of family planning and
CAC services. The consortium collaborates with the Government
of Ghana in expanding women’s access to modern family planning
and comprehensive abortion care. The consortium’s program titled
“Reducing Maternal Morbidity and Mortality” (R3M) program, aims
to increase access to FP services and reduce unwanted pregnancy and
severe complications and deaths caused by unsafe abortions.
As part of the R3M program, Marie Stopes International Ghana
(MSIG) is providing family planning and comprehensive abortion care
services in the private sector. MSIG has established four static “centers
of excellence” clinics, three in Accra and one in Kumasi. These centers
provide a range of sexual and reproductive health services (SRH) at
affordable prices. Part of MSIG’s mandate is to increase access to and
9

utilization of quality, sustainable CAC and FP services through the
establishment of a network of franchised service delivery centers. A
total of 100 franchisees comprising 42 Clinics, 25 Pharmacy shops and
33 Chemical sellers have been recruited and receive technical support
and SRH commodities from MSIG. These franchisees also serve as
referral points for the MSIG Centers. MSIG’s mandate also includes
the introduction of new technologies and procedures for abortion care
and management.
Mifepristone, branded by MSIG as MEDIPRIST, has been granted
temporary approval and permission by the Ghana Food and Drugs
Board (FDB) to be used as a medical abortifacient. Together with
Misoprostol which has already been approved for use in Ghana
by FDB, the two regimen combination will be used for the medical
abortion procedure; an oral administration of 200mg Mifepristone
(MEDIPRIST) ideally in the health facility followed by an oral
administration of 800mg misoprostol 24-48 hours later either in the
facility or any other place of choice for the woman. Complete approval
will be granted primarily based on the outcome of this documentation
process. The FDB registration process includes stringent measures for
documenting usage; one registration condition was for the introduction
to be channeled only through MSIG centers, franchisee clinics and
selected GHS service delivery sites for an initial introductory period
during which time the process will be documented. All providers in
the implementation sites received training from MSIG, the training
included an overview of the product information, including dose
regimen, efficacy, side effects, contra-indications, counseling, and
general norms and procedures for provision of medical abortion.
This study was undertaken by the Population Council as an unbiased
evaluator, taking the lead role in the documentation process to
objectively report on the introduction of the combination regimen
Mediprist and Misoprostol as a Medical Abortifacient. The findings
from this study will inform all stakeholders and lessons learnt will
serve as a guide to MSIG and Ghana Health Service as a whole during
the scale-up stage.
10

Study Objectives
The primary objective of this study was to document the introduction
of Mifepristone and Misoprostol for early medical abortion in Ghana.
The specific objectives were to:
1. Assess the ability of providers and early experience of providers in
the provision of the new regimen;
2. Document the quality of care of abortion services offered at both
private and public health facilities;
3. Document client satisfaction with the medical abortion procedure;
4. Document all client side/adverse effects experienced;
5. Discuss lessons learnt for further refinement and modification 		
before scaling up.

Research Methodology
Study Population

The study population was women in their reproductive age (15 – 49
years old) who sought abortion services from designated facilities in
Accra, Ashanti and Eastern regions. For a woman to be eligible for the
study, she was expected to be in general good health and must have
been assessed by a clinician to have an intrauterine pregnancy that
was less than 49 days on the first day of contact with the study team.
Only the clients who after counseling on the two available methods
chose medical abortion were included in the study. The study used
the following as criteria for selecting eligible women for the study. The
woman must:
• Be willing to participate, consent and be able to endorse an
informed consent form by signature or thumbprint
• Client’s desire to terminate pregnancy
• Be eligible for medical abortion according to the clinician’s
11

assessment
• Be willing to undergo a surgical completion of the abortion if    
necessary
• Have ready and easy access to a telephone or mobile phone
• Agree to comply with the study procedures and visit schedule
The study considered women with any of the following conditions as
ineligible for the study:
• Confirmed or suspected ectopic pregnancy or undiagnosed
adnexal mass
• Chronic renal failure
• Concurrent long-term corticosteroid therapy
• History of allergy to mifepristone, misoprostol or other
• Prostaglandin
• Hemorrhagic disorders or concurrent anticoagulant therapy
• inherited porphyria
• Possible ectopic pregnancy
• IUD/IUS in place
• other serious physical or mental health conditions

Study Design
The study was facility-based: four MSIG static centers in Kumasi and
Accra; and six public health facilities, KBTH, Ridge and La General
Hospitals in Greater Accra Region, Koforidua Regional Hospital and
Oda Government Hospital in Eastern Region and Manhyia Hospital
in Ashanti Region were the study sites. Inclusion of both public and
private health facilities allowed for documentation of the process in the
two settings where services will normally be provided and also provided
a wide range of clients with different backgrounds and experiences.
As stated above, all women in the study received 200mg Mediprist orally
at the facilities during the initial visit followed by an oral administration
of 800mg misoprostol 24-48 hours later either in the facility or any
12

other place of choice for the client. All clients were required to return
to the facilities in 10-14 days for a follow up examination to ensure
complete expulsion, during this visit, clients will be counseled and
provided with their choice of a family planning method to prevent
future unintended pregnancies. As part of the initial counseling, the
importance of the follow-up examination visit is stressed to clients
and they are also provided with token funds to assist with their
transportation expenses for the follow-up visit, a combination which
allowed a high client return rate. Client exit interviews were conducted
immediately after the completion of the examination during follow
up visit. Service providers who offered medical abortion services were
also interviewed. The study team included interviewers who were
each assigned to each of the study sites for the duration of the study.
The women were identified at first visit and then interviewed after
they completed the review visit. Data collection was conducted over a
period of 5 months.

Study Findings
Socio-Demographic and Economic Characteristics of Clients
The study interviewed 477 women in their reproductive age (15 – 49
years old) across ten health care service delivery facilities in three
administrative regions of Ghana namely Greater Accra, Ashanti and
Eastern Regions. These ten health facilities comprise six tertiary care
public health institutions; Koforidua Regional Hospital, KBTH, La
General Hospital, Manhyia Government Hospital, Oda Government
Hospital and Ridge Hospital; and 4 Marie Stopes International centers
of excellence in Ashiaman, Kokomlemle, Manhean and Kumasi.
The socio-demographic and economic characteristics of clients are
shown in Appendix. About three out of five (58.9 percent) clients were
residents of Accra, 11.7 percent resided in Kumasi and approximately
4.5 percent were residents of Koforidua. The remaining 24.9 percent
were residents of nearby communities around Accra, Tema, Kumasi
13

and Koforidua and others coming from Nsawam and Ofoase in the
Eastern Region and as far as Bolgatanga in the Upper East.
A mean age of 25.8 years was reported among clients interviewed with
13.2 percent in their teen years and the rest distributed across the other
age groups (Table 1). More than half (55.0 percent) had never been
married, 26.3 percent were married, 15.8 percent were in consensual
unions (cohabiting) and the remaining three percent were widowed,
divorced or separated.
About six percent (6.3 percent) of the clients had no formal education,
more than half (55.6 percent) had secondary or higher education
and the rest had primary or basic education. The majority of clients
interviewed, 89.5 percent were Christians and 8.6 percent were of the
Islamic faith, the others belonged to a traditional religion or had no
religion. About 49.2 percent of clients interviewed belonged to the
Akan ethnic group while the rest were distributed among Ewe, GaDangme, Mole Dagbani, Guan, and other ethnic groups. About one in
ten clients were unemployed with a little over a quarter (26.5 percent)
employed in the professional/clerical/technical field, 23.6 percent were
students and about twenty two percent were traders (22.3 percent).

Fertility Experience of Clients Interviewed
The mean children ever born among the study sample is relatively
lower than the mean number of pregnancies experienced. While the
average number of children born (live birth) is approximately one
child, the average number of pregnancies experienced is about three as
seen in Table 1. The maximum number of pregnancies experienced by
any client in our sample is 16 while the highest number of live births
is 11 children. The average preferred number of children for our client
sample is about three children. The table does highlight an interesting
fertility behavior pattern worth noting, it shows that on average the
clients have had 1.5 more pregnancies than live births, i.e. most women
interviewed have had 1-2 abortions (or miscarriages) before this visit.
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sample is 16 while the highest number of live births is 11 children. The average preferred
number of children for our client sample is about three children. The table does highlight an
interesting fertility behavior pattern worth noting, it shows that on average the clients have
had
more pregnancies
thanthey
live currently
births, i.e. have
that most
women
interviewed
have had 1-2
Yet,1.5
although
on average
1 child,
they
would prefer
abortions
(or
miscarriages)
before
this
visit.
Yet,
although
on
average
they
currently
to have at least 3 children. A question which we do not address in have 1
child, they would prefer to have at least 3 children. A question which we do not address in
this paper is why are these women having repeated abortions when the
this paper is why are these women having repeated abortions when the average preferred
average preferred number of children and live births is three and one
number of children and live births is three and one respectively?

respectively?

Table 1: Pregnancies and Children Ever Born
Std.
Variable
Mean
Min
Max
Deviation
Preferred # of children
3.1
0
10
1.2
Pregnancies
2.5
0
16
1.9
Live birth
1.0
0
11
1.4
Living children
0.9
0
8
1.3

Number
461
461
461
461

Assessment of Medical Abortion Service Provision: Client Perspective

Assessment of Medical Abortion Service Provision:
During
initial consultation with service providers on the various methods of pregnancy
ClientthePerspective
termination, almost nine in ten (88.7 percent) clients indicated that MVA/EVA was
mentioned
andinitial
discussed
with them. Almost
all (99.4providers
percent) indicated
the medical
During the
consultation
with service
on the that
various
abortion process and eligibility requirements were discussed with them. About 46 percent
methods of pregnancy termination, almost nine in ten (88.7 percent)
(212) clients who came to the health facility had some particular pregnancy termination
clients indicated that MVA/EVA was mentioned and discussed with
method in mind. Among these clients, about half (50.9 percent) had medical abortion in
them.about
Almost
(99.4hadpercent)
indicated
that the
medical
abortion
mind,
48.1 all
percent
termination
by MVA/EVA
in mind
and the
rest mentioned
process
and
requirements
were
discussed
with them.
About
Cipro,
D&C
andeligibility
shots “injection”
which are all
other
forms of termination
methods.

46 percent (212) of clients who came to the health facility had some
About
93.1 percent
of the termination
clients reportedmethod
that they in
feltmind.
that theAmong
service providers
particular
pregnancy
these gave
sufficient
information
on available
options
for pregnancy
termination
during
their first
clients, about
half (50.9
percent)
had medical
abortion
in mind,
about
counseling
consultation.
The
majority,
90.2
percent
and
92.0
percent
respectively
48.1 percent had termination by MVA/EVA in mind and the restindicated
they had the opportunity to ask questions and chose a preferred method for their pregnancy
mentioned Cipro, D&C.
termination. The distribution of the most important reasons for deciding to use medical
abortion is shown in Table 3. The most mentioned reason for deciding to use medical
About was
93.1to percent
of the
that
felt ofthat
the trauma
abortion
avoid surgery
(31.2clients
percent),reported
followed by
the they
avoidance
physical
service
providers
gave
sufficient
information
on
available
options
or pain (25.4 percent). Only about one percent of the clients mentioned more than for
one reason
pregnancy
duringinstead
their offirst
counseling
for
deciding totermination
use medical abortion
surgical
abortion. consultation. The

majority, 90.2 percent and 92.0 percent respectively indicated they had
the opportunity to ask questions and chose a preferred method for
their pregnancy termination. The distribution of the most important
reasons for deciding to use medical abortion is shown in Table 2. The
15
15

most mentioned reason for deciding to use medical abortion was to
avoid surgery (31.2 percent), and to avoid physical trauma or pain (25.4
percent). About one percent of the clients mentioned more than one
reason for deciding to use medical abortion instead of surgical abortion.
Table 2: Reasons for Selection of Medical Abortion
Responses
Number Percent
Reasons
To avoid surgery
144
31.2
To avoid physical trauma/pain
117
25.4
It is less risky/no complications
47
10.2
It was recommended by a friend
41
8.9
Was offered no other option
25
5.4
It is less expensive
23
5.0
To avoid anesthesia
16
3.5
It is less invasive
10
2.2
It is more effective
7
1.5
Other reasons
14
3.0

with Abortion
the Medical
Abortion Procedure
xperience Experience
with the Medical
Procedure

hen the clients visit the health facilities, they are first counseled on the available options
Clients visit the health facilities, they are first counseled on the available
d eligibility
criteria.
part of the
counseling
for of
thethe
medical
abortion
the
options
andAseligibility
criteria.
As part
counseling
forprocedure,
the
ents are informed
of the regimen,
the mode(s)
of administration
theregimen,
medication(s) and
medical abortion
procedure,
the clients
are informed ofofthe
e also toldthe
about
the option
to take the second
eitherand
at the
or at home
mode(s)
of administration
of themedication,
medication(s)
are facility
also told
the two about
medications,
Misoprostol
and
Mediprist
which
were
administered
to
the option to take the second medication, either at the facilityclients, al
d the firstordrug,
Mediprist
administered
the clinic.
As shown administered
in Table 4, approximately
at home.
All clients
had theat first
drug, Mediprist
at
percent of
clients
they
would have preferred
to take
theclients
Misoprostol a
thethe
clinic.
As indicated
shown in that
Table
3, approximately
68 percent
of the
indicated
that
they would
havetopreferred
to take the Mediprist at the
e clinic, with
about 28
percent
preferring
take it at home.
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clinic, with about 28 percent preferring to take it at home.
Table 3: Location Preference for Mediprist Administration
Responses
Preference
Number
Percent
Clinic
313
67.9
Home
129
28.0
Not Terminate Again
11
2.4
Indifferent
8
1.7
Total
461
100

Table 4: Location for Misoprostol Administration
Responses
Preference
Number
Percent
Clinic
280
60.7
Home
181
39.3
Total
461
100

According to the interviewed clients, more than half (60.7 percent) of the them had th
second drug, Misoprostol also administered at the clinic, with 39.3 percent taking th
More
than the
halfclinic,
(60.7 3percent)
of clients
interviewed
had theTable
second
Misoprostol
outside
clients did
not taking
the Misoprostol.
5 shows th
drug,
Misoprostol
also
administered
at
the
clinic,
with
39.3
percent
total number of clients who took Misoprostol outside the health facility. Out of this number
taking
the having
Misoprostol
outside
the clinic,
threetook
clients
did not take
72 of them
reported
someone
with them
when they
the medicine;
Table 6 show
the
Misoprostol.
Table
4
shows
the
total
number
of
clients
who
the distribution of the people who were present with the client. About
61 took
percent of th
clients indicated
having
their partner
present,
21 Out
percent
had number,
their friends
Misoprostol
outside
the health
facility.
of this
72 ofpresent
them when th
drug was reported
taken andhaving
only three
percent
of
clients
who
took
the
Misoprostol
outside
someone with them when they took the medicine; the healt
facility had
their
mother
present
when they
the medication.
Table 5 shows the distribution
oftook
the people
who were present with the

client. About 61 percent of the clients indicated having their partner
present, 21 percent had their friends present when the drug was taken
and only three percent of clients who took the Misoprostol outside the
health facility had their mother present when they took the medication.
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Table 5: Person Present during Administration of Misoprostol

Responses
Person Present
Number
Percent
A husband/boyfriend
43
60.6
Table
5: Person Present during Administration
of21.1
Misoprostol
A friend
15
Mother
2 Responses
2.8
Person
Present
Number
Percent
Other
relatives
6
8.5
A husband/boyfriend
Others
6 43
7.060.6
A friend
21.1
Total
72 15
100.0
Mother
2
2.8
Other
relatives
6
8.5
About three in ten (28.7 percent) clients indicated they experienced
the
About three in tenOthers
(28.7 percent) clients indicated they experienced
the
onset
of expulsion after
6
7.0
onset of expulsion after taking Mediprist. Complete expulsion usually
taking Mediprist. Total
Complete expulsion usually happened within
the first 100.0
6 hours after taking the
happened within
the first
6 hours
afterexperienced
taking72
the complete
second medication,
second medication,
Misoprostol.
About
80 percent
expulsion within the
Misoprostol.
About 80 Misoprostol
percent experienced
expulsion within
first 24 hours
after administering
as shown incomplete
Table 7. Approximately
two percent
needed the
an additional
dose
of
Misoprostol
for
complete
expulsion.
About
9
clients
first 24 hours after administering Misoprostol as shown in Table 6. did not
About three
inexpulsion
ten (28.7 percent)
clients
indicated
they
experienced
the
onset of
expulsion
experience
any
afterpercent
taking
the
medication
and
weredose
thus of
provided
with
a free ofafte
Approximately
two
needed
an additional
Misoprostol
taking
Mediprist.
Complete
expulsion
usually
happened
within
the
first
6
hours
after
taking the
charge surgical
completion.
This conforms
with
other studies
have
shown that
for
complete
expulsion.
About
9 clients
did that
notcomplete
experience
anygenerally
second
medication,
Misoprostol.
About
80
percent
experienced
expulsion
within
under 5% of women who go in for medical abortion do not experience any expulsion and the
expulsion
taking the
medication
andet.
had
surgical
completion
attwo
first 24
hours
afterafter
administering
shown
in
Approximately
would
need
a suction
procedure
to Misoprostol
complete
it as
(Spitz
al,Table
1998)7..)The
success rate
in percen
this
no
cost
to
them.
This
conforms
with
other
studies
that
have
shown
needed
an
additional
dose
of
Misoprostol
for
complete
expulsion.
About
9
clients
study is quite high and could be explained by the relatively low gestational age cap.hoursdidof no
experience
any expulsion
after
the medication
thus abortion
provided with
that
under
5%taking
of women
who go inand
forwere
medical
do a free of
vaginal
dose generally
(WHO
2003)
chargenot
surgical
completion.
This
conforms
with
other
studies
that
have
shown
experience any expulsion and would need a suction procedure that
to generally
under 5% of
women
who
go
in
for
medical
abortion
do
not
experience
any
expulsion
and
Tableit6:(Spitz
Time Taken
for Complete
Expulsion
Misoprostol
complete
et. al, 1998).
The success
rateafter
in this
study is quite
would need a suction procedure to complete it (Spitz et. al, 1998) .)The success rate in this
Lengthand
of Time
Number
Percent
could
explained
by the
low low
gestational
ageage
cap.cap.hours o
study high
is quite high
and be
could
be explained
byrelatively
the relatively
gestational
Less
than(WHO
hours
186
40.3
hours
of6 vaginal
dose (WHO 2003)
vaginal
dose
2003)
Between 6-12 hours
100
21.7
Time Taken for Complete Expulsion84after Misoprostol
BetweenTable
12-24 6:
hours
18.2
More
than
24
hours
75
16.3
Length of Time
Number
Percent
Needed additional dose of misoprostol
7
1.5
Less than 6 hours
186
40.3
Fetus was never expelled
9
2.0
Between 6-12 hours
100
21.7
Total
461
100.0
Between 12-24 hours
84
18.2
More than 24 hours
75
16.3
Needed
additional
dose
of
misoprostol
7
1.5
Known Side Effects of Medical Abortion
Fetus was never expelled
9
2.0
Vomiting
was the most mentioned side effect of both Mediprist and
medication as
Total
461Misoprostol100.0
shown in Tables 8 and 9. This was followed by dizziness, headaches, and diarrhea after taking
Mediprist, and dizziness, nausea, flushes/sweats, and diarrhea after taking Misoprostol.

Known Side Effects of Medical Abortion
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Known Side Effects of Medical Abortion
Vomiting was the least mentioned side effect of both Mediprist and
Misoprostol medication as shown in Tables 7 and 8. As expected, most
clients experienced cramps/pain after taking Misoprostol.
Table 7: Clients’ Experiences of Side Effects of Mediprist
Table 7: Clients’ Experiences of Side Effects of Mediprist
Responses
Responses
Side Effects of Mediprist
Number Percent
Side Effects of Mediprist
Number Percent
Cramps/pain
218
47.3
Cramps/pain
218
47.3
Bleeding
137
29.7
Bleeding
137
29.7
Nausea
98
21.3
Nausea
98
21.3
Chills
89
19.3
Chills
89
19.3
Flushes/sweats
86
18.7
Flushes/sweats
86
18.7
Diarrhea
86
18.7
Diarrhea
86
18.7
Headaches
85
18.4
Headaches
85
18.4
Dizziness
77
16.7
Dizziness
77
16.7
Vomiting
62
13.4
Vomiting
62
13.4

Table 8: Clients’ Experiences of Side Effects of Misoprostol
Table 8: Clients’ Experiences of Side Effects of Misoprostol
Client Responses
Client Responses
Side Effects of Misoprostol
Number
Percent
Side
Effects
of
Misoprostol
Number
Bleeding
432 Percent
93.7
Bleeding
432
93.7
Cramps/pain
415
90.0
Cramps/pain
415
90.0
Chills
151
32.8
Chills
151
32.8
Diarrhea
148
32.1
Diarrhea
148
32.1
Headaches
144
31.2
Headaches
144
31.2
Flushes/sweats
128
27.8
Flushes/sweats
128
27.8
Dizziness
115
24.9
Dizziness
115
24.9
Nausea
104
26.6
Vomiting
80
17.4
Nausea
104
26.6
Vomiting
80
17.4
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Clients had very varying experiences with side-effects; the most
mentioned side-effect experienced by clients after taking just the
Mediprist was cramps/pain for which they generally took pain
medication. After taking the second medication Misoprostol, the clients
reported that nausea was the most mentioned side effect experienced;
this is most likely an effect of the combination of the two medications.
The majority of the clients (77.8 percent) reported that they did not feel
any effects or changes in their body function which can be linked to the
medication or abortion at the time of the study.

Service Providers’ Training and Knowledge about Medical
Abortion
It is essential that service providers are knowledgeable about the
services they provide as this allows them to provide the services
more professionally which will result in high acceptance and high
satisfaction. All the interviewed providers are health professionals
with the following technical qualification distribution: 10 midwives,
2 nurses and 1 medical assistant. The average number of years’ service
providers had worked in their respective health facilities at the time of
the study was 6 years with highest being 17 years and the least, 1 year.
All interviewed service providers had received training to provide
medical abortion services from at least one of the following
organizations; Ipas, Marie Stopes International Ghana, and Gynuity in
collaboration with Ghana Health Service between 2005 and 2009. The
average number of years providers had been introduced to medical
abortion is 4 years with a maximum of 9 years and a minimum of
less than a year. There have been in previous years a few small-scale
medical abortion studies mainly based in single facilities which some
of the providers were exposed to, these have all been one-off, short
period studies.
To ascertain the confidence level of providers in the provision of the MA
services they were asked to rank their knowledge and understanding
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few small-scale medical abortion studies mainly based in single facilities which some of the
providers were exposed to, these have all been one-off, short period studies.
To ascertain the confidence level of providers in the provision of the MA services they were
on the administration of the MA medication. A significant proportion
asked to rank their knowledge and understanding on the administration of the MA
of providers; 92.4 percent ranked themselves as having excellent and
medication. A significant proportion of providers; 92.4 percent ranked themselves as having
very good
knowledge
on theonadministration
medication.
excellent
and very
good knowledge
the administrationofofMA
MA medication.
As As
shown on
shown
in
Table
9
only
7.6
percent
ranked
themselves
as
having
good
Table 10 only 7.6 percent ranked themselves as having good knowledge about
the drug
knowledge about
the None
drug ranked
administration
Noneknowledge.
ranked This
administration
procedure.
themselves procedure.
as having poor
themselves
poor
knowledge.
Thisthecorresponds
the
corresponds
withasthehaving
percentage
of providers
who knew
accurate dosagewith
of Mediprist.

percentage of providers who knew the accurate dosage of Mediprist.

Table 9: Ranked Provider Knowledge on Medical Abortion Drug Administration
Client Responses
Knowledge about drug
administration
Excellent
Very good
Good
Total

Percent
46.2
46.2
7.6
100.0

Almost
all (92.3
percent)
service providers
knew the accurate
dosage of
Almost
all (92.3
percent)
service providers
knew and
therecommended
accurate and
Mediprist
per case (200mg).
Providers
wereper
asked
about
the ineligibility
criteriawere
for medical
recommended
dosage of
Mediprist
case
(200mg).
Providers
abortion
service.
As
shown
in
Table
11,
the
most
mentioned
was
history
of
allergy to
asked about the ineligibility criteria for medical abortion service.
prostaglandin, followed by chronic renal failure and confirmed or suspected ectopic
As shown in Table 10, the most mentioned was history of allergy to
pregnancy. Other ineligibility criteria mentioned were concurrent long-term corticosteroid
prostaglandin, followed by chronic renal failure and confirmed or
therapy, hemorrhagic disorders or concurrent anticoagulant therapy and the least mentioned
suspected
ectopic
pregnancy. Other ineligibility criteria mentioned
criteria
was inherited
porphyries.

were concurrent long-term corticosteroid therapy, hemorrhagic
disorders or concurrent anticoagulant therapy and the least mentioned
criteria was inherited porphyries. 20

Table 10: Service Provider Knowledge of Ineligibility Criteria for Mediprist
Responses
Ineligibility criteria
Number Percent
History of allergy to prostaglandin
7
53.8
Confirmed or suspected ectopic pregnancy
6
46.2
Chronic renal failure
6
46.2
Concurrent long-term corticosteroid therapy
4
30.8
Hemorrhagic disorders or concurrent anticoagulant therapy
3
23.1
Inherited porphyries
1
7.7
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Satisfaction and Acceptance of Medical Abortion
The acceptance of a new intervention in a general population depends
significantly on the level of satisfaction experienced by initial users.
Aggregated levels of satisfaction generally give a more accurate level of
satisfaction among the general population.
The level of satisfaction derived from the medical abortion service
was measured by both client and provider satisfaction. Providers
of reproductive health care services including medical abortion
services are a critical component in the successful introduction and
implementation of any health intervention policy, program or product.
Their satisfaction, comfort and acceptance of a product and/or a service
allows for better provider-client interaction generally leading to higher
client satisfaction rates. In the case of providers, about 11 out of the 13
providers indicated that they were satisfied with the product, the other
two providers felt they were not entirely certain of the efficacy of the
medication, however almost all (12 out of 13) the service providers were
of the opinion that clients were satisfied with the product. This shows
the level of acceptance of the product by service producers which will
be pivotal in scaling up of the program to a larger population.
As can be seen from Table 11, about 94 percent of the clients were
satisfied with the medication abortion procedure. However, about 4
percent were indifferent and about 3 percent were not satisfied with the
medical abortion procedure.
Table 11: Percent Distribution of Clients by Level of Satisfaction
Responses
Levels
Number Percent
Very Satisfactory
201
43.6
Satisfactory
230
49.9
Indifferent
17
3.7
Unsatisfactory
5
1.1
Very Unsatisfactory
8
1.7
Total
461
100
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The level of client’s satisfaction with the medical abortion procedure was translated in their

Unsatisfactory
Very Unsatisfactory
Total

5
8
461

1.1
1.7
100

The level of client’s satisfaction with the medical abortion procedure
translated
in theirwith
confirmation
that theyprocedure
would recommend
The levelwas
of client’s
satisfaction
the medical abortion
was translatedthe
in their
procedure
otherrecommend
friends, family
and relations
as wellfamily
as choosing
confirmation
that theytowould
the procedure
to other friends,
and relations
procedure
again inagain
the in
future
should
it become
necessary.
as well asthe
choosing
the procedure
the future
should
it become
necessary.About
About four
fourpercent)
in five (82.9
indicated
they
will select
method
in five (82.9
clientspercent)
indicatedclients
they will
select the
method
again, the
while
about 90.0
again,
while
about
90.0
percent
indicated
that
they
will
recommend
percent indicated that they will recommend the method to their family and friends.
the method to their family and friends.

Difficulties
andofChallenges
of Medical
Abortion in Ghana
Difficulties
and Challenges
Medical Abortion
in Ghana
The mostThe
mentioned
associated
with the
provision of
medical
as reported
most challenge
mentioned
challenge
associated
with
the abortion
provision
of
by the providers
is
the
persistent
calls
they
received
from
clients.
According
to
the
medical abortion as reported by the providers is the persistent providers,
calls
there is anthey
associated
levelfrom
of uncertainty
they usually
tell exactly
received
clients. because
According
to the cannot
providers,
therethe
is severity
an
of what really
is
happening
to
the
client.
Some
providers
also
indicated
that,
for
a
few
clients
associated level of uncertainty because they usually cannot tell exactly
(about 7 clients), there was a need to repeat the Misoprostol which they were not very
the severity of what really is happening to the client. Some providers
comfortable in administering. Finally, one provider indicated that failure to get call back from
also indicated that, for a few clients (about 7 clients), there was a need
clients who took the medication home is usually disturbing because one cannot tell what
to repeat the Misoprostol which they were not very comfortable in
might have happened to them.

administering. Finally, one provider indicated that failure to get call
back from clients who took the medication home is usually disturbing
because one cannot tell what might have happened to them.
Table 12: Provider Challenges Associated with Medical Abortion
Responses
Challenges
Number Percent
No challenges
7
53.8
Persistent calls from client
3
23.1
Additional dose of Misoprostol
2
15.4
No call back because client took drug home
1
7.7
Total
13
100

Clients on
the other
hand
had hand
varying
during medical
abortion
process.
Clients
on the
other
hadexperiences
varying experiences
during
medical
Abdominal
pains and/or
waistAbdominal
pains were pains
the most
mentioned
associated
abortion
process.
and/or
waistworst
painsexperiences
were the most

mentioned worst experiences associated with the procedure. This was
followed by abdominal cramps and excessive bleeding/discharge.
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with
with the
the procedure.
procedure. This
This was
was
bleeding/discharge.
bleeding/discharge.

followed
by abdominal
abdominal cramps
cramps and
and excessive
excessive
followed by

Table
of Worst
Worst Experience
Experience by
by Clients
Clients
Table 13:
13: Distribution
Distribution of
Client’s Responses
Responses
Client’s
Worst
Experience
Number
Percent
Worst Experience
Number Percent
Abdominal
pains
or
waist
pains
185
32.3
Abdominal pains or waist pains
185
32.3
Abdominal
99
17.3
Abdominal cramps
cramps
99
17.3
Excessive
79
13.8
Excessive bleeding
bleeding // Discharge
Discharge
79
13.8
No
18
3.1
No side
side effect
effect
18
3.1
Vomiting
17
3.0
Vomiting
17
3.0
Bleeding
15
2.6
Bleeding
15
2.6
Uncomfortable
13
2.3
Uncomfortable
13
2.3
Nausea
12
2.1
Nausea
12
2.1
Very
2.1
Very painful like during labor
12
2.1
Severe
1.9
Severe chills / offensive odor / feverishness
11
1.9
Pregnancy
1.6
Pregnancy not completely terminated
9
1.6
Weakness
1.4
Weakness in my legs and joints
8
1.4
Headaches
8
1.4
Headaches
1.4
Diarrhea
6
1.0
Diarrhea
1.0
Extra
money
spent
for
pads
6
1.0
Extra
1.0
Severe
menstrual
pains
4
0.7
Severe
0.7
Needed
additional
dose
for
a
complete
expulsion
4
0.7
Needed
0.7
Surgical
method
needed
for
completion
4
0.7
Surgical
0.7
Loss
of
appetite
2
0.3
Loss
0.3
Discharge
of
blood
clots
1
0.2
Discharge
0.2
Had
4.9
Had no
no significant side effect
28
4.9
The
best
experience of
the
expulsion of
of
The
of the
theentire
entireprocess
process
according
to clients
the clients
wasexpulsion
Thebest
bestexperience
according
to the
was the
product
of
conception
within
a
short
time.
procedure
was
very
product
They
also
indicated
that
the
procedure
was
very
the expulsion of product of conception within a short time. They also
effective
some
of them, bleeding
waseffective
flow.
effective and
just like normal
menstrual
indicated
thatforthe
procedure
was very
and for
some flow.
of
them,
bleeding was just like normal menstrual flow.
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Table 14: Percent Distribution of best Experience of Procedure by Clients
Client’s
Responses
Best Experience
Number Percent
Had an expulsion of the fetus within short time
148
29.2
Bleeding was just like normal menstrual flow
77
15.2
It was very effective
59
11.6
Medication was easily taken
43
8.5
Happy about the complete abortion
28
5.5
Affordable
21
4.1
Ensures more privacy
11
2.2
Nothing was good about this procedure
9
1.8
To avoid surgical method
6
1.2
Can do the insertion yourself
6
1.2
More effective than Misoprostol alone therapy
6
1.2
Avoided any physical trauma / pains
5
1.0
Checked and monitored by health providers
5
1.0
Pain was just for a short while
4
0.8
Coming to the facility to have it done
3
0.6
Severe abdominal cramps
2
0.4
The provider was always nice to me
2
0.4
No side effect / No complication
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Scaling up and Sustainability of Program and Product Services
Scaling up and Sustainability of Program and Product Services

Scaling up and sustaining the program will depend on availability
Scaling up and sustaining the program will depend on availability of the products and
ofaffordability
the products
affordability
of the
Sameanasaverage
charges
of the and
service.
Same as charges
for service.
MVA services,
pricefor
of GH¢40
MVA
services, by
an service
averageproviders
price offrom
GH¢40
mentioned
by service
was mentioned
both was
the private
and public
sector as the
providers
from
bothclients
the private
andforpublic
sector
the recommended
recommended
amount
should pay
the service.
Asas
shown
in table 16, to ensure that
more women
have
accesspay
to for
this the
life service.
saving procedure,
more
fiftywomen
percent of the
amount
clients
should
To ensure
thatthan
more
interviewed
service
providers
recommend
that
there
should
be
intense
counseling
have access to this life saving procedure, more than fifty percent of the and
education about
the procedure.
interviewed
service
providers recommend that there should be intense
counseling and education about the procedure.
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Conclusion
The principal focus of this documentation study is multifold. It
concerns the perception, acceptance of the methods by clients who opt
for it. It also documents from the client’s perspective, acceptability, side
effects associated with the method, and finally from providers, comfort
in the provision of the service. The study further examined the skills
and quality of service providers of medical abortion offered to their
clients. The mean age of the clients was 25.8 years with 13.2% of them
in their teen ages. The majority of them (55%) had never married;
the average number of children ever born (life birth) is one while the
average number of pregnancy experienced is about three.
Providers took clients through counseling and allowed clients to
choose a method, approximately 93 percent of the clients reported
that providers gave them sufficient information on methods during
their first counseling consultation. It is also important to note that,
about 50 percent of the clients had medical abortion in mind before
visiting the facility, whiles about 48 percent had MVA/EVA in mind.
Among the clients who took the Misoprostol at home, about 78
percent of them reported that they preferred to be alone during the
drug administration. This reinforces the notion that typically, women
who go in for an abortion would not want it to be known to others.
This also highlights the fact that due to the high stigmatization of the
procedure, nobody wants to be publicly associated with abortion.
Acceptability of medical abortion was very high, about 81 percent of
the clients indicated that they will use the method again if they had to,
while 89.5 percent indicated that they will recommend the method to
their friends, approximately 85 percent of the providers were satisfied
with the product.
The most noted side effect of Misoprostol was cramping. Among those
who reported of side effect from the medical abortion process, 62.9
percent required some pain medication and treatment. Approximately
78 percent of the clients did not feel any effect or changes in their body
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as a result of medical abortion at the time of the study. Whiles more
than 80 percent of the clients’ experienced complete expulsion within
24 hours after administration of Misoprostol, about 16 percent had
their expulsion after 24 hours with two percent needing additional
dose and two percent needing a surgical completion.
Although the study showed high satisfaction with the method from
clients and providers, the study identified one major challenge which
needs to be addressed. This challenge has to do with getting clients to
return to the facility for a follow-up visit where they would be examined
to ascertain complete expulsion. Counseling should be intensified such
that clients will feel the importance in them returning to the facility for
a follow-up visit.
There are several advantages and disadvantages to either the surgical
or medical abortion. The major advantage that the medical abortion
has over the surgical is that the risk of surgery and use of anesthesia is
avoided and the medical abortion procedure is generally less painful.
The main disadvantages of medication over surgical abortion is that
the duration for completion of the process is longer and is generally
not recommended after a certain gestation period.
Overall the study has shown that medical abortion is a viable option
for Ghanaian women, an overwhelming number of those who have
benefitted from the procedure are content and will use or recommend
it. The report shows that in Ghana, the women who used the procedure
had no life threatening side effects at the time of their review visit. Most
of the women interviewed reported headaches and cramps which are
well known and documented side effects. Based on the findings of this
report, it is highly recommended that more providers get trained in
the provision of the service and most importantly the complementary
counseling that it requires. The products and service should be made
easily accessible and available to all women especially the vulnerable
in order to stem the mortality rates associated with unsafe abortion.
This study has shown that medical abortion is an effective method for
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first trimester up to 56 days of amenorrhea abortion; however medical
abortion should not be viewed as a replacement but rather an alternative
to surgical abortion.
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AppendixAppendix
Table 15: Study Sample by Socio-Demographic Characteristics
Socio-demographic characteristics
Percent Number
Age group
15-19
20-24
25-29
30-34
35-39
40-44

13.2
32.3
30.6
14.5
6.3
3.1

63
154
146
69
30
15

Never married
Married
Cohabiting
Widowed
Divorced
Separated

55.0
26.3
15.8
0.4
1.5
1.1

262
125
75
2
7
5

Highest Level of Education
No schooling
Primary
Middle/JSS/JHS
Sec/SSS/Tec/Vocational
Higher

6.3
11.1
27.1
35.1
20.4

30
53
129
167
97

Religion
Christianity
Islam
Traditionalist
No religion
Other

89.5
8.6
0.2
1.3
0.4

426
41
1
6
2

49.2
16.7
19.1

232
79
90

Marital Status

Ethnicity
Akan
Ewe
Ga-Dangme

31

Traditionalist
No religion
Other
Ethnicity
Akan
Ewe
Ga-Dangme
Mole Dagbani
Guan
Other
Trading/Vending for employer
Trading/Vending
Main Occupationfor oneself
Apprentice
Housewife
Student
Agricultural worker
Unemployed
Professional/Clerical/Technical
Other

28

32

0.2
1.3
0.4

1
6
2

49.2
16.7
19.1
10.2
2.8
2.1
5.5
22.3
6.9
2.1
23.6
0.2
11.2
26.5
1.7

232
79
90
48
13
10
26
106
33
10
112
1
53
126
8

